Hormone replacement therapy and a risk for breast cancer in postmenopausal women: analysis of some epidemiological studies


Cite item

Full Text

Abstract

The paper provides an epidemiological update on a risk for breast cancer during menopausal hormone replacement therapy. It gives the results of large observational and randomized clinical trials, as well as the point of view of the International Menopause Society in the context of evidence-based medicine.

About the authors

V N Konovalova

ФГУ Научный центр акушерства, гинекологии и перинатологии им. В. И. Кулакова Росмедтехнологий, Москва

канд. мед. наук, науч. сотр. отд-ния гинекологической эндокринологии (дир. - акад. РАМН Г. Т. Сухих); ФГУ Научный центр акушерства, гинекологии и перинатологии им. В. И. Кулакова Росмедтехнологий, Москва

V P Smetnik

ФГУ Научный центр акушерства, гинекологии и перинатологии им. В. И. Кулакова Росмедтехнологий, Москва

ФГУ Научный центр акушерства, гинекологии и перинатологии им. В. И. Кулакова Росмедтехнологий, Москва

V N Konovalova

V P Smetnik

References

  1. American Cancer Society. Breast cancer facts and figures 2003-2004. http://www.cancer.org/downloads/STT/ CAFF2003BrFPWSecured.pdg.
  2. Black W. C., Welch H. G. // N. Engl. J. Med. - 1993. - Vol. 328. - P. 1237-1243.
  3. Chen C. L. et al. // J. A. M. A. - 2002. - Vol. 287. - P. 734- 741.
  4. Chlebowski R. T. et al. // J. A. M. A. - 2003. - Vol. 289. - P. 3243-3253.
  5. Colditz G. A. et al. // N. Engl. J. Med. - 1995. - Vol. 330. - P. 1589-1599.
  6. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer // Lancet. - 1997. - Vol. 350. - P. 1047-1059.
  7. Darmasetiawan M. S. // Menopause Dig. - 2004. - Vol. 16, N 5. - P. 5-8.
  8. Foidart J. M. et al. // Climacteric. - 2007. - Vol. 10, N 2. - P. 54-61.
  9. Fournier A. et al. // Int. J. Cancer. - 2005. - Vol. 114, N 3. - P. 448-454.
  10. Fournier A. et al. // Breast Cancer Res. Treat. - 2008. - Vol. 107, N 1. - P. 103-111.
  11. Garland M. et al. // Am. J. Epidemiol. - 1998. - Vol. 147, N 7. - P. 636-643.
  12. Heikkinen J., Vaheri R., Timonen U. // J. Br. Menopause Soc. - 2006. - Vol. 12, N 3. - P. 115-125.
  13. Hulley S. et al. // J. A. M. A. - 1998. - Vol. 280. - P. 605- 613.
  14. Kenemans P., van der Mooren J. // Gynaecol. Forum. - 2004. - Vol. 9, N 3. - P. 15-17.
  15. Key T. J. et al. // Lancet Oncol. - 2001. - Vol. 2. - P. 133- 140.
  16. Magnusson C. et al. // Cancer Causes Control. - 1998. - Vol. 9, N 3. - P. 259-267.
  17. Million Women Study Collaborators. Breast cancer and hormone replacement therapy in the Million Women Study // Lancet. - 2003. - Vol. 362. - P. 419-427.
  18. Newcomb P. A. et al. // Cancer Epidemiol. Biomarker. Prev. - 2002. - Vol. 11. - P. 593-600.
  19. Olsson H. L. et al. // Cancer. - 2003. - Vol. 97. - P. 1387- 1392.
  20. Pines A. et al. International Menopause Society. // Summary of the First IMS Global Summit on menopause-related issues. - March 29-30, 2008.
  21. Porch J. V. et al. // Cancer Causes Control. - 2002. - Vol. 13. - P. 847-854.
  22. Ross R. K. et al. // J. Natl. Cancer. Inst. - 2000. - Vol. 92. - P. 328-332.
  23. Shapiro S. // Climacteric Medicine - where do we go? / Eds H. P. G. Schneider, T. Naftolin. - London; New York, 2005. - P. 166-174.
  24. Sitruk-Ware R. // Menopause. - 2002. - Vol. 9. - P. 6-15.
  25. Vogel V. G. // Menopause. - 2008. - Vol. 15, N 4. - P. 782- 789.
  26. Weiss L. K. et al. // Obstet. and Gynecol. - 2002. - Vol. 100. - P. 1148-1158.
  27. Wysowski D. K. et al. // Obstet. and Gynecol. - 1995. - Vol. 85, N 1. - P. 6-10.

Copyright (c) 2011 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies